These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Obstetric antiphospholipid syndrome: still a challenge. Levy RA; Jesús GR; Jesús NR Lupus; 2010 Apr; 19(4):457-9. PubMed ID: 20353988 [TBL] [Abstract][Full Text] [Related]
7. Obstetric antiphospholipid syndrome: a recent classification for an old defined disorder. D'Ippolito S; Meroni PL; Koike T; Veglia M; Scambia G; Di Simone N Autoimmun Rev; 2014 Sep; 13(9):901-8. PubMed ID: 24820522 [TBL] [Abstract][Full Text] [Related]
9. Pregnancy Outcome in Women with Obstetric and Thrombotic Antiphospholipid Syndrome-A Retrospective Analysis and a Review of Additional Treatment in Pregnancy. Mayer-Pickel K; Eberhard K; Lang U; Cervar-Zivkovic M Clin Rev Allergy Immunol; 2017 Aug; 53(1):54-67. PubMed ID: 27395067 [TBL] [Abstract][Full Text] [Related]
10. Antiphospholipid syndrome. Khamashta M; Taraborelli M; Sciascia S; Tincani A Best Pract Res Clin Rheumatol; 2016 Feb; 30(1):133-48. PubMed ID: 27421221 [TBL] [Abstract][Full Text] [Related]
11. Antiphosphatidylserine/prothrombin Antibodies in Antiphospholipid Syndrome with Intrauterine Growth Restriction and Preeclampsia. Canti V; Del Rosso S; Tonello M; Lucianò R; Hoxha A; Coletto LA; Vaglio Tessitore I; Rosa S; Manfredi AA; Castiglioni MT; Ruffatti A; Rovere-Querini P J Rheumatol; 2018 Aug; 45(9):1263-1272. PubMed ID: 30008452 [TBL] [Abstract][Full Text] [Related]
12. Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2 -glycoprotein i domain 1 and domain 4/5: ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndrome. Andreoli L; Chighizola CB; Nalli C; Gerosa M; Borghi MO; Pregnolato F; Grossi C; Zanola A; Allegri F; Norman GL; Mahler M; Meroni PL; Tincani A Arthritis Rheumatol; 2015 May; 67(8):2196-204. PubMed ID: 25939498 [TBL] [Abstract][Full Text] [Related]
13. Risk factors for pregnancy morbidity in women with antiphospholipid syndrome. Yang J; Liang M J Reprod Immunol; 2021 Jun; 145():103315. PubMed ID: 33845396 [TBL] [Abstract][Full Text] [Related]
14. What have we learned about antiphospholipid syndrome from patients and antiphospholipid carrier cohorts? Pengo V; Banzato A; Bison E; Bracco A; Denas G; Ruffatti A Semin Thromb Hemost; 2012 Jun; 38(4):322-7. PubMed ID: 22399307 [TBL] [Abstract][Full Text] [Related]
15. Role of tissue factor in thrombosis in antiphospholipid antibody syndrome. Boles J; Mackman N Lupus; 2010 Apr; 19(4):370-8. PubMed ID: 20353972 [TBL] [Abstract][Full Text] [Related]
16. The journey of antiphospholipid antibodies from cellular activation to antiphospholipid syndrome. Willis R; Gonzalez EB; Brasier AR Curr Rheumatol Rep; 2015 Mar; 17(3):16. PubMed ID: 25761923 [TBL] [Abstract][Full Text] [Related]
17. Pathogenesis of antiphospholipid syndrome: understanding the antibodies. Meroni PL; Borghi MO; Raschi E; Tedesco F Nat Rev Rheumatol; 2011 Jun; 7(6):330-9. PubMed ID: 21556027 [TBL] [Abstract][Full Text] [Related]
18. Women's Issues in Antiphospholipid Syndrome. Papadakis E; Banti A; Kioumi A Isr Med Assoc J; 2016 Sep; 18(9):524-529. PubMed ID: 28471597 [TBL] [Abstract][Full Text] [Related]